E
Optimind Pharma Corp. OMND
CNSX
Recommendation
Sell
Prev Close
$0.005
Volume
--
Avg Vol (90D)
15,241
Market Cap
$380.92K
Dividend & Yield
--
52-Week Range
$0.005 - $0.01
P/E (TTM)
--
EPS (TTM)
-$0.0064
My Lists My Alerts
Weiss Ratings OMND - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Rating E
Reward Index Very Weak
Risk Index Weak
Risk Grade D-
Reward Grade E
Rating Factors OMND - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Dividend Index --
Growth Index Fair
Efficiency Index Very Weak
Solvency Index Weak
Total Return Index Weak
Volatility Index Weak
Beta / Standard Deviation OMND - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Beta -1.60
Price History OMND - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
7-Day Total Return 0.00%
30-Day Total Return 0.00%
60-Day Total Return 0.00%
90-Day Total Return 0.00%
Year to Date Total Return 0.00%
1-Year Total Return 0.00%
2-Year Total Return -90.00%
3-Year Total Return --
5-Year Total Return --
52-Week High % Change -50.00%
52-Week Low % Change 0.00%
Price OMND - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
52-Week High Price $0.01
52-Week Low Price $0.01
52-Week Low Price (Date) Apr 11, 2024
52-Week High Price (Date) May 24, 2024
Valuation OMND - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Market Cap 380.92K
Enterprise Value 396.92K
Price/Earnings (TTM) --
Earnings Per Share (TTM) -0.01
Earnings Per Share Growth -68.47%
Price/Earnings To Growth --
Price/Sales (TTM) 7.14
Price/Book (Q) -16.67
Enterprise Value/Revenue (TTM) 4.82
Price $0.01
Enterprise Value/EBITDA (TTM) -4.02
Enterprise Value/EBIT -1.70
Market Cap Category Nano Cap
Dividends and Shares OMND - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Shares Outstanding 109.79M
Dividend Yield --
Div. Per Share (Most Recent) --
Dividend Per Share (TTM) --
Payout Ratio (TTM) --
Dividend Per Share (Most Recent) --
Company Info OMND - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Phone Number 647-891-9379
Address 77 King Street West Toronto, ON M5K 1G8
Website optimindpharma.com
Country Canada
Year Founded --
Profitability OMND - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Operating Margin (TTM) -284.33%
Profit Margin -812.60%
Management Effectiveness OMND - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Return on Assets -39.16%
Return on Equity --
Income Statement OMND - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Revenue (TTM) 81.70K
Total Revenue (TTM) 81.70K
Revenue Per Share $0.00
Gross Profit (TTM) 53.30K
EBITDA (TTM) -98.10K
EBIT (TTM) -232.30K
Net Income (TTM) -663.90K
Net Income Avl. to Common (TTM) -663.90K
Total Revenue Growth (Q YOY) -1.03%
Earnings Growth (Q YOY) 91.37%
EPS Diluted (TTM) -0.01
EPS Diluted Growth (Q YOY) 87.50%
Balance Sheet OMND - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Cash and Short-Term Inv. (Q) 73.20K
Cash Per Share (Q) $0.00
Total Current Assets (Q) 116.30K
Total Preferred Equity (Q) --
Total Equity (Q) -34.40K
Current Ratio (Q) 0.624
Book Value Per Share (Q) $0.00
Total Assets (Q) 152.00K
Total Current Liabilities (Q) 186.30K
Total Debt (Q) 89.70K
Total Liabilities (Q) 186.30K
Total Common Equity (Q) -34.40K
Cash Flow OMND - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Cash from Investing (TTM) -200.00
Cash from Financing (TTM) 197.20K
Net Change in Cash (TTM) 51.80K
Levered Free Cash Flow (TTM) -54.60K
Cash from Operations (TTM) -145.20K
Weiss Ratings